Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating expenses:        
General and administrative $ 676,399 $ 268,120 $ 1,016,571 $ 536,049
Research and development 157,023 361,273 294,127 547,317
Total operating expenses 833,422 629,393 1,310,698 1,083,366
NET LOSS $ (833,422) $ (629,393) $ (1,310,698) $ (1,083,366)
Net loss per share of common shares, basic and diluted $ (0.31) $ (0.32) $ (0.55) $ (0.55)
Weighted-average number of common shares outstanding, basic and diluted 2,719,198 1,978,269 2,370,082 1,978,269